Wound Dressing Binding Layer for Negative Pressure Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing negative-pressure wound therapy systems face challenges in managing high-viscosity wound exudates, particularly those with high protein content, which can lead to occlusions and pressure drops, disrupting the effective application of negative pressure and impeding wound healing.

Innovation Solution

The proposed therapy system includes a bridge with a binding layer that has bacterial-binding and protein-binding properties, positioned between manifold layers and sealed within a sealing material. This configuration helps to bind proteins and bacteria, preventing them from obstructing fluid pathways and maintaining effective negative pressure transmission.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional wound dressings are used without binding material, then the device structure remains simple, but high-viscosity wound exudates with high protein content cause occlusions and pressure drops in fluid pathways

Engineering Contradiction:
Improvenegative pressure transmissionVSAvoidbridge structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

A binding layer comprising binding material is introduced as an intermediary component between the wound exudate and the fluid pathways. This binding material specifically binds to proteins and bacteria in the exudate, preventing them from obstructing the fluid pathways while maintaining negative pressure transmission. The binding layer acts as a mediator that captures harmful substances before they can cause occlusions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The binding layer is constructed using porous materials that allow fluid flow while providing sufficient surface area for binding interactions. The porous structure enables wound exudate to pass through while trapping proteins and bacteria, preventing occlusions in the downstream fluid pathways without compromising the negative pressure transmission capability.

Inventive Principle:
Principle #31Porous materials

2Reliability

If binding material is added to the bridge, then protein and bacterial accumulation is prevented, but the device complexity increases

Engineering Contradiction:
Improvefluid pathway patencyVSAvoidbridge structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The binding layer is integrated into the existing bridge structure by combining it with either the sealing material or the manifold layers. This merging approach incorporates the binding functionality without requiring a completely separate, complex assembly process. The binding material is positioned between the sealing material and the manifold layers, creating a unified multi-functional component.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The bridge structure is designed to perform multiple functions simultaneously: maintaining fluid pathways, transmitting negative pressure, and binding proteins and bacteria. By incorporating the binding layer into the bridge, the structure becomes multi-functional, eliminating the need for separate components and reducing overall device complexity despite adding binding capability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If binding layer is positioned between manifold layers, then protein binding effectiveness is improved, but manufacturing complexity increases

Engineering Contradiction:
Improveprotein binding efficiencyVSAvoidbridge assembly
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The binding layer is nested between the first and second manifold layers, creating a compact multi-layer structure. This nesting arrangement allows the binding material to be positioned optimally for protein binding effectiveness while maintaining a space-efficient design that can be manufactured using layer-by-layer assembly processes.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The binding layer is pre-positioned between the manifold layers during bridge manufacturing, rather than being added separately during clinical application. This preliminary action ensures optimal positioning for protein binding while simplifying the overall manufacturing process by integrating multiple functions into a single assembly step.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of a binding layer in the bridge of the therapy system effectively manages high-viscosity wound exudates by preventing protein and bacterial accumulation, thereby reducing pressure drops and ensuring consistent negative pressure application, which enhances wound healing outcomes.

Implementation Method 1

a binding layer comprising binding material having bacterial-binding as well as protein-binding properties

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentEP3700596B1Wound dressing for use with Anti-bacterial material
Publication Date: 2025.06.04 SOLVENTUM INTELLECTUAL PROPERTIES CO
  • EP3700596B1 patent drawingFigure 1~4
  • EP3700596B1 patent drawingFigure 2
  • EP3700596B1 patent drawingFigure 3A

AI summary

A portable therapy system for treating a tissue site, particularly a venous leg ulcer, is disclosed. In some embodiments, the therapy system may include a bridge, a dressing, or both, which contain a material suitable for binding bacteria and/or protein. Such a binding material may be used in conjunction with one or more manifold or wicking layers disposed within the bridge or the dressing to help contain bacteria and/or protein present in fluid extracted from the tissue site, such as wound exudate. By binding the bacteria and/or protein present in wound exudate, particularly wound exudate that may possess a high viscosity due to a greater concentration of proteins, blockages and associated pressure drops across the components of the therapy system may thus be minimized or avoided.